Odyssey Health (ODYY) Return on Capital Employed (2016 - 2026)
Odyssey Health (ODYY) posted quarterly Return on Capital Employed of 9.8% for Q2 2026, up 36.0% year-over-year from 7.21% in Q2 2025, and up 38.55% quarter-over-quarter from 7.07% in Q1 2026.
Odyssey Health (ODYY) Return on Capital Employed (2016 - 2026) Analysis & Trends
Odyssey Health's Return on Capital Employed history runs 11 years deep, the most recent figure standing at 9.8% for Q2 2026.
- In Q2 2026, Return on Capital Employed rose 36.0% year-over-year to 9.8%; the TTM figure through Apr 2026 stood at 9.8% (up 36.0% YoY), while the FY2025 annual figure was 15.27%, down 2436.0% from the prior year.
- Return on Capital Employed for Q2 2026 stood at 9.8%, up from 7.07% in the prior quarter.
- The five-year high for Return on Capital Employed was 466.87% in Q1 2022, with the low at 166.76% in Q1 2024.
- The 5-year median for Return on Capital Employed is 22.6% (2025), against an average of 65.67%.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed plunged 68784 bps in 2022, then jumped 18032 bps in 2025.
- Odyssey Health's Return on Capital Employed stood at 158.24% in 2022, then slumped by 64 bps to 56.91% in 2023, then tumbled by 47 bps to 30.4% in 2024, then plunged by 66 bps to 10.34% in 2025, then declined by 5 bps to 9.8% in 2026.
- Business Quant data shows ODYY's Return on Capital Employed at 9.8% in Q2 2026, 7.07% in Q1 2026, and 10.34% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 12.08% |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | 9.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 9.80% |
| Jan 31, 2026 | 7.07% |
| Oct 31, 2025 | 10.34% |
| Jul 31, 2025 | 14.80% |
| Apr 30, 2025 | 9.44% |
| Jan 31, 2025 | 13.55% |
| Oct 31, 2024 | 30.40% |
| Jul 31, 2024 | -141.21% |
| Apr 30, 2024 | -31.20% |
| Jan 31, 2024 | -166.76% |
| Oct 31, 2023 | 56.91% |
| Jul 31, 2023 | 86.18% |
| Apr 30, 2023 | 111.83% |
| Jan 31, 2023 | 160.04% |
| Oct 31, 2022 | 158.24% |
| Jul 31, 2022 | 175.51% |
| Apr 30, 2022 | 210.30% |
| Jan 31, 2022 | 466.87% |
| Oct 31, 2021 | 531.14% |
| Jul 31, 2021 | 676.15% |